News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Molineaux Christopher P.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 06/05/2023 |
4
| Molineaux Christopher P. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 15,750 options to buy
@ $8.7, valued at
$137k
Granted 4,660 restricted stock units
@ $0
Exercised 4,507 restricted stock units
@ $0 |
|
| 06/06/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/04/2021 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/08/2020 |
4
| Molineaux Christopher P. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 16,500 options to buy
@ $1.41, valued at
$23.3k
Exercised 7,333 restricted stock units
@ $0 |
|
| 03/04/2020 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/10/2019 |
4
| Molineaux Christopher P. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 7,333 restricted stock units
@ $0 |
|
| 06/08/2018 |
4
| Molineaux Christopher P. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $18.35, valued at
$146.8k
|
|
| 04/09/2018 |
4
| Molineaux Christopher P. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Sold 2,300 shares
@ $16.52, valued at
$38k
|
|
| 03/22/2018 |
4
| Molineaux Christopher P. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Exercised 1,993 options to buy
@ $0.41, valued at
$817.1
Exercised 120 options to buy
@ $0.72, valued at
$86.4
Exercised 264 options to buy
@ $1.52, valued at
$401.3 |
|
| 06/16/2017 |
4
| Molineaux Christopher P. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 8,000 options to buy
@ $24.58, valued at
$196.6k
|
|
| 03/21/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 07/01/2016 |
4
| Molineaux Christopher P. (Director) has filed a Form 4 on Aclaris Therapeutics, Inc.|
Txns:
| Granted 6,632 options to buy
@ $18.32, valued at
$121.5k
|
|
|
|